Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3935 EUR | +0.90% | -0.13% | -14.46% |
05-07 | GenSight Biologics S.A. announced that it expects to receive ?1.546199 million in funding | CI |
04-05 | GenSight: financial visibility assured until the end of April | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.46% | 42.86M | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-3.17% | 21.58B | |
-10.81% | 18.96B | |
-13.41% | 16.33B | |
-40.50% | 16.96B | |
+6.64% | 14.14B | |
+31.84% | 12.02B |
- Stock Market
- Equities
- SIGHT Stock
- News GenSight Biologics S.A.
- GenSight Biologics S A : Says Blind Patient Partially Recovers In Phase 1/2 Study of Optogenetic Therapy; Shares Up 7%